Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer

D. D'Ugo, R. Persiani, S. Rausei, A. Biondi, V. Vigorita, S. Boccia, R. Ricci

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Aims: Aim of this study is the evaluation of the effects induced by neoadjuvant chemotherapy (NACT) and its impact on survival on a series of locally advanced gastric carcinomas. Methods: Downstaging was assessed comparing pre-treatment clinical and laparoscopic staging with post-operative pathologic staging on 30 consecutive patients who completed a 3-year follow-up. Tumor downstaging and the grade of pathologic response were included in a statistical correlation between tumor regression induced by NACT and 3-year survival. Results: In this series tumor downstaging was obtained in 13 out of 30 patients. After the completion of 3-year follow-up, overall survival was >37.5 months with an overall survival rate of 56.7%; this figure reached up to 70.8% in those cases who benefited from a R0-resection (24/30 patients: R0-resection rate 80.0%). Conclusions: In this study the 3-year survival for locally advanced gastric cancer treated by NACT prior to "D2" surgical resection, compares favourably with historical series treated by surgery alone. Patients who obtained T-downstaging and subsequently benefited from a R0-resection had a definitely better chance of cure, according to a complete 3-year follow-up.

Original languageEnglish
Pages (from-to)1105-1109
Number of pages5
JournalEuropean Journal of Surgical Oncology
Volume32
Issue number10
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Stomach Neoplasms
Drug Therapy
Survival
Neoplasms
Stomach
Survival Rate
Carcinoma
Therapeutics

Keywords

  • Laparoscopic staging
  • Locally advanced gastric cancer
  • Neoadjuvant chemotherapy
  • Pathologic response
  • Tumor downstaging

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer. / D'Ugo, D.; Persiani, R.; Rausei, S.; Biondi, A.; Vigorita, V.; Boccia, S.; Ricci, R.

In: European Journal of Surgical Oncology, Vol. 32, No. 10, 12.2006, p. 1105-1109.

Research output: Contribution to journalArticle

D'Ugo, D. ; Persiani, R. ; Rausei, S. ; Biondi, A. ; Vigorita, V. ; Boccia, S. ; Ricci, R. / Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer. In: European Journal of Surgical Oncology. 2006 ; Vol. 32, No. 10. pp. 1105-1109.
@article{68cbb755ad134554ae996fab03348e3f,
title = "Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer",
abstract = "Aims: Aim of this study is the evaluation of the effects induced by neoadjuvant chemotherapy (NACT) and its impact on survival on a series of locally advanced gastric carcinomas. Methods: Downstaging was assessed comparing pre-treatment clinical and laparoscopic staging with post-operative pathologic staging on 30 consecutive patients who completed a 3-year follow-up. Tumor downstaging and the grade of pathologic response were included in a statistical correlation between tumor regression induced by NACT and 3-year survival. Results: In this series tumor downstaging was obtained in 13 out of 30 patients. After the completion of 3-year follow-up, overall survival was >37.5 months with an overall survival rate of 56.7{\%}; this figure reached up to 70.8{\%} in those cases who benefited from a R0-resection (24/30 patients: R0-resection rate 80.0{\%}). Conclusions: In this study the 3-year survival for locally advanced gastric cancer treated by NACT prior to {"}D2{"} surgical resection, compares favourably with historical series treated by surgery alone. Patients who obtained T-downstaging and subsequently benefited from a R0-resection had a definitely better chance of cure, according to a complete 3-year follow-up.",
keywords = "Laparoscopic staging, Locally advanced gastric cancer, Neoadjuvant chemotherapy, Pathologic response, Tumor downstaging",
author = "D. D'Ugo and R. Persiani and S. Rausei and A. Biondi and V. Vigorita and S. Boccia and R. Ricci",
year = "2006",
month = "12",
doi = "10.1016/j.ejso.2006.07.009",
language = "English",
volume = "32",
pages = "1105--1109",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer

AU - D'Ugo, D.

AU - Persiani, R.

AU - Rausei, S.

AU - Biondi, A.

AU - Vigorita, V.

AU - Boccia, S.

AU - Ricci, R.

PY - 2006/12

Y1 - 2006/12

N2 - Aims: Aim of this study is the evaluation of the effects induced by neoadjuvant chemotherapy (NACT) and its impact on survival on a series of locally advanced gastric carcinomas. Methods: Downstaging was assessed comparing pre-treatment clinical and laparoscopic staging with post-operative pathologic staging on 30 consecutive patients who completed a 3-year follow-up. Tumor downstaging and the grade of pathologic response were included in a statistical correlation between tumor regression induced by NACT and 3-year survival. Results: In this series tumor downstaging was obtained in 13 out of 30 patients. After the completion of 3-year follow-up, overall survival was >37.5 months with an overall survival rate of 56.7%; this figure reached up to 70.8% in those cases who benefited from a R0-resection (24/30 patients: R0-resection rate 80.0%). Conclusions: In this study the 3-year survival for locally advanced gastric cancer treated by NACT prior to "D2" surgical resection, compares favourably with historical series treated by surgery alone. Patients who obtained T-downstaging and subsequently benefited from a R0-resection had a definitely better chance of cure, according to a complete 3-year follow-up.

AB - Aims: Aim of this study is the evaluation of the effects induced by neoadjuvant chemotherapy (NACT) and its impact on survival on a series of locally advanced gastric carcinomas. Methods: Downstaging was assessed comparing pre-treatment clinical and laparoscopic staging with post-operative pathologic staging on 30 consecutive patients who completed a 3-year follow-up. Tumor downstaging and the grade of pathologic response were included in a statistical correlation between tumor regression induced by NACT and 3-year survival. Results: In this series tumor downstaging was obtained in 13 out of 30 patients. After the completion of 3-year follow-up, overall survival was >37.5 months with an overall survival rate of 56.7%; this figure reached up to 70.8% in those cases who benefited from a R0-resection (24/30 patients: R0-resection rate 80.0%). Conclusions: In this study the 3-year survival for locally advanced gastric cancer treated by NACT prior to "D2" surgical resection, compares favourably with historical series treated by surgery alone. Patients who obtained T-downstaging and subsequently benefited from a R0-resection had a definitely better chance of cure, according to a complete 3-year follow-up.

KW - Laparoscopic staging

KW - Locally advanced gastric cancer

KW - Neoadjuvant chemotherapy

KW - Pathologic response

KW - Tumor downstaging

UR - http://www.scopus.com/inward/record.url?scp=33751167229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751167229&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2006.07.009

DO - 10.1016/j.ejso.2006.07.009

M3 - Article

C2 - 16930932

AN - SCOPUS:33751167229

VL - 32

SP - 1105

EP - 1109

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 10

ER -